Method of treating glaucoma with oligonucleotides
US5545626A · kind A · utility
22Cited by
1References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 19, 1994 |
| Grant date | Aug 13, 1996 |
| Priority date | — |
| Expiry date | Jan 19, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/549
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of treating glaucoma which comprises administering to a subject an effective amount of an oligonucleotide which may be substituted or modified in its phosphate, sugar, or base, so as to decrease intraocular pressure and thereby treat the glaucoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.